JBRA Assist. Reprod. 2025;29(4):806-811
UPDATE ARTICLE
doi: 10.5935/1518-0557.20250029
Bisphenol A and human fertility: a systematic review
1Pontificia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil
2Federal University of Rio Grande do Sul, Porto Alegre, Brazil
3Fertilitat - Medical Reproductive Center, Porto Alegre, Brazil
CONFLICT OF INTEREST
The authors have nothing to disclose.
ABSTRACT
Considering the significant exposure to the synthetic compound bisphenol A (BPA), present in a wide range of materials in our daily lives, this article discusses a possible correlation between this substance and human fertility through a bibliographic review. In the context of growing evidence that BPA impacts the fertility of women and men of reproductive age, the reviewed articles suggest that exposure to this agent may affect ovarian reserve parameters in women. In pregnant women, it may cause fetal malformations. BPA has also been linked to an increase in spontaneous abortions and premature births. Additionally, it can cause hormonal disruptions, affect folliculogenesis, and worsen ovarian response in assisted reproduction, as well as lead to lower estradiol concentrations, reduced fertilization rates, and higher implantation failure. In men of reproductive age, BPA may decrease sperm production, potentially contributing to testicular dysgenesis syndrome and cryptorchidism. However, further studies are still required to better understand the diverse and complex mechanisms through which BPA affects key reproductive functions.
Keywords: bisphenol A (BPA), human fertility, endocrine disruptors, assisted reproduction, sperm production
INTRODUCTION
Bisphenol A (BPA) is a synthetic compound consisting of two phenolic rings connected by a methyl bridge, and it is used in a wide range of everyday products, including general packaging, DVDs, computers, electronic devices, coatings for food and beverage cans, toys, dental materials, disposable cups and cutlery, medical equipment, thermal paper, and products for children and babies. It is widely used in the production of polycarbonate plastics and epoxy resins. Human exposure to this substance is so extensive that contact can be considered continuous (Konieczna et al., 2015; Pallotti et al., 2020). Exposure to BPA occurs through oral, inhalation, and transdermal routes, via the objects in which it is present.
Studies have demonstrated that BPA interacts with estrogen receptors and can act as either an agonist or antagonist through endocrine receptor-dependent signaling pathways (Konieczna et al., 2015). This interaction can lead to hormonal changes, consequently suggesting the risk of ovarian cysts and breast cancer (Konieczna et al., 2015).
There is growing evidence that BPA impacts both female and male fertility. In women of reproductive age, the exposure to BPA may affect ovarian reserve parameters (Czubacka et al., 2021). In pregnant women, BPA may cause fetal malformations and even miscarriage. In man, BPA may reduce sperm production, potentially leading to testicular dysgenesis syndrome and cryptorchidism (Matuszczak et al., 2019). However, further human studies are needed to better understand its long-term consequences, particularly on offspring.
Thus, the objective of this present study was to review the currently available literature on this subject.
METHODS
This article is based on bibliographic research and a descriptive-documentary study, following the format of a systematic review. An advanced search was conducted on the Public Medline database platform (PubMed), Scientific Electronic Library Online (SciELO), and Latin American and Caribbean Health Sciences Literature (LILACS), and was performed in September 2024. The database search used the keywords ‘infertility’ and ‘bisphenol A,’ applying the Boolean operator ‘AND.’ Scientific articles discussing the impact of bisphenol A on male and female fertility were included in the study, focusing on hormonal dysregulation affecting the hormonal cycle, gamete quality, fertilization problems, and subsequent issues in pregnancy.
Articles published in English from 2012 onward were selected. The study excluded case reports, book chapters, letters to the editor, viewpoints, studies with hypothetical data or scenario simulations, and studies that did not meet the inclusion criteria. This search yielded a total of 158 studies.
Each manuscript was evaluated based on its title and abstract, according to the inclusion criteria. The full versions of the selected documents were then reviewed by three independent reviewers. Of the studies evaluated, 57 were excluded for not meeting the inclusion criteria, leaving 101 articles for abstract review, and finally, 28 were included for full-text reading and the development of this review.
The flowchart of search and selection process, so that it is clearer how the included articles were selected, is presented below on Figure 1. The type of each study chosen is presented in Table 1.
Figure 1. The flowchart of search and selection process.* Created by the authors.
Table 1. The type of each study chosen was created by the authors.
LITERATURE REVIEW
The widespread use of BPA has raised concerns about its impact on human health, including reproductive health. This review examines data from recent literature to understand the implications of BPA exposure on reproductive health. The findings were separated by four topics: “changes in female and male fertility”, “assisted reproduction”, “gestational changes” and “other effects”.
Changes in female and male fertility
In recent years, more studies have been published on the association between BPA and its analogs with male and female fertility, widely linking it to various adverse effects, including the disruption of hormonal balance, negative impacts on ovarian function, and potentially compromised fertility. A recently published systematic review and meta-analysis consistently found an association between BPA exposure and reproductive disorders, attributed to BPA’s ability to mimic estrogen and interfere with ovarian function, thereby affecting fertility (Lü et al., 2024). Additionally, provided experimental evidence that even low levels of BPA exposure can lead to reproductive cellular toxicity, highlighting its detrimental effects. BPA interacts with estrogen receptors and can act as both an agonist and antagonist through endocrine receptor-dependent signaling pathways, contributing to the pathogenesis of various endocrine disorders, early puberty, and hormone-dependent tumors, such as breast and prostate cancer. The occurrence of polycystic ovary syndrome (PCOS) has also been linked to BPA exposure (Chen et al., 2013; Konieczna et al., 2015; Sifakis et al., 2017; Vessa et al., 2022; Thacharodi et al., 2023).
Although the exact mechanism by which BPA interferes with fertility is still unclear, studies have shown that BPA levels may be associated with decreased antral follicle counts and reduced oocyte counts (Konieczna et al., 2015; Sifakis et al., 2017). Furthermore, animal models exposed to BPA have reported the occurrence of endometriosis-like lesions (Pivonello et al., 2020). During the postnatal and pubertal periods and into adulthood, BPA seems to affect the hypothalamic-pituitary-testicular axis by modulating hormone synthesis (e.g., LH, FSH, androgens, and estrogens), as well as the expression and function of their respective receptors. These effects alter sperm parameters (Zhang et al., 2023). BPA also may induce oxidative stress in the testes and epididymis by inhibiting antioxidant enzymes and promoting lipid peroxidation. This suggests that the use of antioxidants may be a promising strategy to mitigate BPA-induced disorders (Zhang et al., 2023). Additionally, men exposed to BPA have shown reduced libido, retrograde ejaculation, and erectile dysfunction (Zhang et al., 2023).
Furthermore, studies demonstrate alterations in protein profiles related to fertility in spermatozoa following exposure to BPA, and these changes appear to be associated with a decline in fertilization rates and embryonic development (Rahman et al., 2015; 2017; 2018). Several authors of the analyzed studies have drawn a parallel between BPA exposure and sperm quality. For example, some researchers investigated urinary phenols and semen parameters in a large case-control study, comparing idiopathically infertile men with fertile controls. They found a significant association between alkylphenols and idiopathic male infertility with abnormal seminal parameters, but this association was not found with other phenols included in the analysis, only with BPA (Chen et al., 2013). Another study also demonstrated that physiologically detectable concentrations of BPA can impair sperm function by suppressing protein tyrosine phosphorylation (Li et al., 2021).
Studies conducted by Chen et al. (2013) reveal that BPA, at concentrations greater than 10⁻6M, inhibits the proliferation of Leydig cells. It was found that 50 proteins were modulated in these cells after exposure to BPA. Significant effects were observed on the structure, motility, cellular metabolism, protein and nucleotide processing, and cellular proliferation of these cells.
The study also demonstrated that, at micromolar concentrations or higher, BPA can modulate protein profiles, inhibit cell proliferation, and promote the in vitro migration and invasion of Leydig TM3 cells, a Leydig cell that was isolated from a male mouse, which can be explained by the modulation of proteins related to cell structure and motility, such as actin and heat shock proteins (Chen et al., 2013).
There is chemical’s potential role in reduced sperm count and motility and, corroborating these findings, a recently published study concluded that BPA exposure may negatively impact male fertility, highlighting reduced sperm quality and altered hormone levels in men (Zhang et al., 2023). Besides, BPA exposure impairment on male fertility is associated with endocrine-disrupting chemicals but its exact hole is still under investigation (Zlatnik, 2016).
Hence, considering both male and female reproductive health when assessing BPA’s overall impact is important to fully understand how it affects both genders. There is an urge for more research to fully understand the extent of BPA’s impact on reproductive human health, given the variability of studies’ findings (Zlatnik, 2016).
Assisted Reproduction
Studies have shown an association between BPA and a worsened ovarian response, a lower number of mature oocytes collected and fertilized, and a reduced concentration of estradiol (E2) in response to hyperstimulation with gonadotropin. This was further associated with lower fertilization rates and increased implantation failure. Embryo quality in women undergoing IVF treatment was also affected (Sifakis et al., 2017). It is believed that exposure to high concentrations of BPA may increase the apoptosis of cells that play a crucial role in oocyte protection. However, limited information is available regarding the effects of BPA exposure in adults on ovarian reserve (Chiang et al., 2017; Almeida et al., 2018), and the studies remain controversial. For instance, Mínguez-Alarcón et al. (2015) found that urinary BPA concentrations were not associated with endometrial wall thickness, peak estradiol levels, the proportion of high-quality embryos, or fertilization rates. Additionally, no association was found between urinary BPA concentrations and implantation, clinical pregnancy, or live birth rates per cycle initiated or per embryo transfer (Mínguez-Alarcón et al., 2015).
However, urinary BPA was detected in the majority of samples collectewd from women seeking infertility treatments (Souter et al., 2013). These findings support in vitro results and animal studies, highlighting the potential risk of BPA exposure to human reproductive health.
Mansur et al. (2016) demonstrated that treating luteinized granulosa cells with BPA resulted in a significant decrease in estradiol and progesterone biosynthesis, which was confirmed by a notable reduction in mRNA and protein expression levels of three genes encoding steroidogenesis enzymes: CYP11A1, 3β-HSD, and CYP19A1. However, this effect was observed only at very high, supra-physiological levels. The results suggest that BPA levels detected in blood, urine, and ovarian follicles do not negatively affect granulosa cell steroidogenesis in vitro. These conclusions may be reassuring for women trying to conceive, given the ubiquity of BPA exposure (Mansur et al., 2016).
Uterine changes
Using animal models (rats), it was found that low doses of BPA affect uterine development, leading to fewer implantation sites and various changes in the endocrine pathways that regulate endometrial preparation for embryo implantation. The study reported that early changes in the expression of the HOXA10 gene disrupt the functional differentiation of the uterus during pregnancy, as part of an altered endocrine signal transduction pathway (Zhou et al., 2019).
Gestational changes
The impact of BPA on pregnancy outcomes is a critical area of concern, as BPA exposure has been associated with an increased risk of miscarriage, preterm birth, and other adverse pregnancy outcomes (Li et al., 2021). The authors confirmed these findings through a meta-analysis showing a significant association between BPA exposure and miscarriage risk.
Additionally, BPA exposure may potentially alter endometrial function and impact fetal development at various stages of pregnancy, suggesting that the effects of this chemical extend beyond conception to include gestation and birth outcomes (Guo et al., 2023).
Maternal exposure to BPA during fetal development presents a greater risk to the developing organism. Exposure during this phase is associated with disrupted testosterone production and reproductive tract development, as demonstrated by in vivo and in vitro detection of multiple antiandrogen endocrine disruptors. Fetal life is a critical phase when sex is determined by the differentiation of reproductive tissues-a fundamental step for the future development and maintenance of reproductive function. In the male fetus, these processes rely on the initiation and maintenance of androgenic activity (Pallotti et al., 2020).
Such processes, however, can be disrupted by endocrine disruptors at various levels, including androgen receptor (AR) antagonism and interference in steroid hormone synthesis. Disruption of these processes can result in damage to reproductive tissues while the fetus is still in the womb, leading to malformations such as hypospadias, cryptorchidism, testicular hypertrophy, reduced anogenital distance, impaired future fertility, altered spermatogenesis, infertility, and the development of testicular tumors (Pallotti et al., 2020). BPA may be associated with several defects in the embryo, such as feminization of male fetuses, atrophy of the testicles and epididymis, increased prostate size, and alterations in adult sperm parameters (e.g., sperm count, motility, and density), and also may affect the development of the embryonic thyroid (Manfo et al., 2014).
Various endocrine disruptors, including BPA, are still widely detected in the environment, and the quantity of these substances that would be harmful to health remains unknown. The period of sexual differentiation appears to be particularly susceptible to the negative effects of environmental pollutants-exposure to phthalates, for example, has been linked to a higher incidence of developmental anomalies (Knez, 2013).
BPA exposure during pregnancy also affects brain development, potentially inducing anxiety, an increased risk of autistic behaviors, impaired memory and learning, as well as changes in social behaviors (Almeida et al., 2018). Moreover, BPA exposure induces specific gender-related alterations, with dose-dependent and brain-region-dependent expression of genes encoding estrogen receptors (ERs, ERα, ERβ, and ER) (Almeida et al., 2018). Additionally, the formation of new memories may be affected, as BPA appears to interfere with neuronal plasticity processes. BPA reduces synaptic density, increases the length of the synaptic cleft, reduces the length of the active zone, and decreases postsynaptic density in the hippocampus (Eilam-Stock et al., 2012; Kundakovic et al., 2013; Almeida et al., 2018). It is important to note that interpreting the results of these studies, especially those related to behavior, can be challenging, as some inherent factors and variables may distort the conclusions. Furthermore, a longitudinal study found that BPA concentrations in maternal urine were associated with increased anxiety and depression in boys, but not in girls, at seven years of age (Almeida et al., 2018).
In a random-effects meta-analysis of prenatal BPA exposure and hyperactivity showed that early BPA exposure in humans was associated with hyperactivity in both boys and girls. One explanation for BPA’s interference with the central nervous system is its association with a decrease in total thyroxine in pregnant women and in thyroid-stimulating hormone (TSH) in newborn males (Rochester & Bolden, 2015).
Additionally, prenatal low-dose BPA exposure in a rat model showed changes in thyroid receptor expression in the fetal neocortex. This evidence suggests that perinatal hypothyroxinemia caused by BPA exposure during pregnancy may lead to neurological deficits (Almeida et al., 2018). The dopamine system is also affected by early BPA exposure, which may explain certain behaviors, such as anxiety. The number of dopamine neurons appears to decrease in the midbrain, along with interference in the activity of tyrosine hydroxylase, the rate-limiting enzyme for dopamine synthesis (Almeida et al., 2018).
CONCLUSION
The present study aimed to evaluate the possible association of BPA with human reproductive function. The reviewed literature consistently indicates that exposure to BPA has significant implications for reproductive health in both males and females, with evidence suggesting risks even at low doses. Current findings highlight BPA’s role as an endocrine disruptor that can interfere with hormonal balance, ovarian function, and pregnancy outcomes. While the included studies provide a solid foundation, further human research is necessary to fully understand the mechanisms of these effects, the potential long-term consequences, and how to develop strategies to mitigate these risks through assisted reproductive technologies.
Limitations of the study
Even though the extensive review of available literature on the effects of Bisphenol A (BPA) on reproductive health, several limitations should be considered when interpreting the results of this study. First of all, the majority of the included studies are observational or experimental, which often carry inherent biases and limitations in establishing causality. Many of the studies rely on self-reported data for exposure assessment, which may be subject to recall bias and inaccuracies. Furthermore, variations in study design, such as differences in sample size, population demographics, and exposure levels, may affect the generalizability of the findings. In addition, there is a lack of standardized protocols for measuring BPA exposure, making it difficult to compare results across studies. Moreover, the long-term effects of BPA exposure, especially at low doses, remain uncertain due to the absence of large, long-term cohort studies. Subsequently, while this review highlights significant associations between BPA exposure and various reproductive health outcomes, it is important to recognize that BPA is just one of many environmental endocrine-disrupting chemicals, and future studies should explore the combined effects of multiple exposures.
ACKNOWLEDGEMENTS
The authors would like to thank all the researchers whose studies were reviewed in this work, providing the foundation for our analysis and insights. We also extend our gratitude to our colleagues and peers for their valuable feedback and support throughout the research process.
REFERENCES
Almeida S, Raposo A, Almeida-González M, Carrascosa C. Bisphenol A: Food Exposure and Impact on Human Health. Compr Rev Food Sci Food Saf. 2018;17:1503-17. PMID: 33350146 DOI: 10.1111/1541-4337.12388 Medline
Chen M, Tang R, Fu G, Xu B, Zhu P, Qiao S, Chen X, Xu B, Qin Y, Lu C, Hang B, Xia Y, Wang X. Association of exposure to phenols and idiopathic male infertility. J Hazard Mater. 2013;250-251:115-21. PMID: 23435201 DOI: 10.1016/j.jhazmat.2013.01.061 Medline
Chiang C, Mahalingam S, Flaws JA. Environmental Contaminants Affecting Fertility and Somatic Health. Semin Reprod Med. 2017;35:241-9. PMID: 28658707 DOI: 10.1055/s-0037-1603569 Medline
Czubacka E, Wielgomas B, Klimowska A, Radwan M, Radwan P, Karwacka A, Kałużny P, Jurewicz J. Urinary Bisphenol A Concentrations and Parameters of Ovarian Reserve among Women from a Fertility Clinic. Int J Environ Res Public Health. 2021;18:8041. PMID: 34360336 DOI: 10.3390/ijerph18158041 Medline
Eilam-Stock T, Serrano P, Frankfurt M, Luine V. Bisphenol-A impairs memory and reduces dendritic spine density in adult male rats. Behav Neurosci. 2012;126:175-85. PMID: 22004261 DOI: 10.1037/a0025959 Medline
Guo J, Liu K, Yang J, Su Y. Prenatal exposure to bisphenol A and neonatal health outcomes: A systematic review. Environ Pollut. 2023;335:122295. PMID: 37532216 DOI: 10.1016/j.envpol.2023.122295 Medline
Knez J. Endocrine-disrupting chemicals and male reproductive health. Reprod Biomed Online. 2013;26:440-8. PMID: 23510680 DOI: 10.1016/j.rbmo.2013.02.005 Medline
Konieczna A, Rutkowska A, Rachoń D. Health risk of exposure to Bisphenol A (BPA). Rocz Panstw Zakl Hig. 2015;66:5-11. PMID: 25813067 Medline
Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, Champagne FA. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci U S A. 2013;110:9956-61. PMID: 23716699 DOI: 10.1073/pnas.1214056110 Medline
Li N, Kang H, Peng Z, Wang HF, Weng SQ, Zeng XH. Physiologically detectable bisphenol A impairs human sperm functions by reducing protein-tyrosine phosphorylation. Ecotoxicol Environ Saf. 2021;221:112418. PMID: 34146982 DOI: 10.1016/j.ecoenv.2021.112418 Medline
Manfo FP, Jubendradass R, Nantia EA, Moundipa PF, Mathur PP. Adverse effects of bisphenol A on male reproductive function. Rev Environ Contam Toxicol. 2014;228:57-82. PMID: 24162092 DOI: 10.1007/978-3-319-01619-1_3 Medline
Mansur A, Adir M, Yerushalmi G, Hourvitz A, Gitman H, Yung Y, Orvieto R, Machtinger R. Does BPA alter steroid hormone synthesis in human granulosa cells in vitro? Hum Reprod. 2016;31:1562-9. PMID: 27112698 DOI: 10.1093/humrep/dew088 Medline
Matuszczak E, Komarowska MD, Debek W, Hermanowicz A. The Impact of Bisphenol A on Fertility, Reproductive System, and Development: A Review of the Literature. Int J Endocrinol. 2019;2019:4068717. PMID: 31093279 DOI: 10.1155/2019/4068717 Medline
Mínguez-Alarcón L, Gaskins AJ, Chiu YH, Williams PL, Ehrlich S, Chavarro JE, Petrozza JC, Ford JB, Calafat AM, Hauser R; EARTH Study Team. Urinary bisphenol A concentrations and association with in vitro fertilization outcomes among women from a fertility clinic. Hum Reprod. 2015;30:2120-8. PMID: 26209788 DOI: 10.1093/humrep/dev183 Medline
Pallotti F, Pelloni M, Gianfrilli D, Lenzi A, Lombardo F, Paoli D. Mechanisms of Testicular Disruption from Exposure to Bisphenol A and Phtalates. J Clin Med. 2020;9:471. PMID: 32046352 DOI: 10.3390/jcm9020471 Medline
Pivonello C, Muscogiuri G, Nardone A, Garifalos F, Provvisiero DP, Verde N, de Angelis C, Conforti A, Piscopo M, Auriemma RS, Colao A, Pivonello R. Bisphenol A: an emerging threat to female fertility. Reprod Biol Endocrinol. 2020;18:22. PMID: 32171313 DOI: 10.1186/s12958-019-0558-8 Medline
Rahman MS, Kwon WS, Karmakar PC, Yoon SJ, Ryu BY, Pang MG. Gestational Exposure to Bisphenol A Affects the Function and Proteome Profile of F1 Spermatozoa in Adult Mice. Environ Health Perspect. 2017;125:238-45. PMID: 27384531 DOI: 10.1289/EHP378 Medline
Rahman MS, Kwon WS, Lee JS, Yoon SJ, Ryu BY, Pang MG. Bisphenol-A affects male fertility via fertility-related proteins in spermatozoa. Sci Rep. 2015;5:9169. PMID: 25772901 DOI: 10.1038/srep09169 Medline
Rahman MS, Kwon WS, Ryu DY, Khatun A, Karmakar PC, Ryu BY, Pang MG. Functional and Proteomic Alterations of F1 Capacitated Spermatozoa of Adult Mice Following Gestational Exposure to Bisphenol A. J Proteome Res. 2018;17:524-35. PMID: 29198108 DOI: 10.1021/acs.jproteome.7b00668 Medline
Rochester JR, Bolden AL. Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes. Environ Health Perspect. 2015;123:643-50. PMID: 25775505 DOI: 10.1289/ehp.1408989 Medline
Sifakis S, Androutsopoulos VP, Tsatsakis AM, Spandidos DA. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems. Environ Toxicol Pharmacol. 2017;51:56-70. PMID: 28292651 DOI: 10.1016/j.etap.2017.02.024 Medline
Souter I, Smith KW, Dimitriadis I, Ehrlich S, Williams PL, Calafat AM, Hauser R. The association of bisphenol-A urinary concentrations with antral follicle counts and other measures of ovarian reserve in women undergoing infertility treatments. Reprod Toxicol. 2013;42:224-31. PMID: 24100206 DOI: 10.1016/j.reprotox.2013.09.008 Medline
Thacharodi A, Hassan S, Acharya G, Vithlani A, Hoang Le Q, Pugazhendhi A. Endocrine disrupting chemicals and their effects on the reproductive health in men. Environ Res. 2023;236:116825. PMID: 37544467 DOI: 10.1016/j.envres.2023.116825 Medline
Vessa B, Perlman B, McGovern PG, Morelli SS. Endocrine disruptors and female fertility: a review of pesticide and plasticizer effects. F S Rep. 2022;3:86-90. PMID: 35789730 DOI: 10.1016/j.xfre.2022.04.003 Medline
Zhang M, Deng YL, Liu C, Lu WQ, Zeng Q. Impacts of disinfection byproduct exposures on male reproductive health: Current evidence, possible mechanisms and future needs. Chemosphere. 2023;331:138808. PMID: 37121289 DOI: 10.1016/j.chemosphere.2023.138808 Medline
Zhou Z, Lei Y, Wei W, Zhao Y, Jiang Y, Wang N, Li X, Chen X. Association between prenatal exposure to bisphenol a and birth outcomes: A systematic review with meta-analysis. Medicine (Baltimore). 2019;98:e17672. PMID: 31689782 DOI: 10.1097/MD.0000000000017672 Medline
Zlatnik MG. Endocrine-Disrupting Chemicals and Reproductive Health. J Midwifery Womens Health. 2016;61:442-55. PMID: 27391253 DOI: 10.1111/jmwh.12500 Medline